Assyro AI

FDA PDUFA dates in July 2026

Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in July 2026, sourced from FDA primary records.

Tracking 10 published FDA PDUFA decisions, including 7 NDAs and 3 BLAs.

FDA PDUFA dates in July 2026: 10 published FDA PDUFA target action dates.
SponsorProductTypeApplicationPDUFA dateStatus
Ascelia PharmaOrviglanceNDAPENDING-provisional|asceliapharma|orviglance|liverimaginupcoming
Vera TherapeuticsataciceptBLAPENDING-provisional|veratherapeutics|atacicept|iganephroupcoming
Daiichi Sankyo and AstraZenecaENHERTUBLAPENDING-provisional|daiichisankyoandastrazeneca|enhertu|upcoming
Corcept Therapeuticsrelacorilant + nab-paclitaxelNDAPENDING-provisional|corcepttherapeutics|relacorilantnabpupcoming
CelcuitygedatolisibNDAPENDING-provisional|celcuity|gedatolisib|hrpositiveher2nupcoming
Elevar Therapeuticsrivoceranib + camrelizumabNDAPENDING-provisional|elevartherapeutics|rivoceranibcamrelupcoming
SanofiSarclisa SCBLAPENDING-provisional|sanofi|sarclisasc|multiplemyeloma|20upcoming
Otsuka PharmaceuticalcentanafadineNDAPENDING-provisional|otsukapharmaceutical|centanafadine|aupcoming
MannKindFUROSCIX ReadyFlow AutoinjectorNDAPENDING-provisional|mannkind|furoscixreadyflowautoinjectupcoming
Viatrislow-dose estrogen weekly patchNDAPENDING-provisional|viatris|lowdoseestrogenweeklypatch|cupcoming

Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.

July 2026 FDA PDUFA Calendar: Drug Approval Dates & Deadlines

Track July 2026 FDA PDUFA dates for NDA, BLA, ANDA, and IND decisions. Free drug approval tracker with source-linked deadlines, calendar views, and daily updates.